Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer Patients

Paul van der Leest, Pieter A Boonstra, Arja Ter Elst, Léon C van Kempen, Marco Tibbesma, Jill Koopmans, Anneke Miedema, Menno Tamminga, Harry J M Groen, Anna K L Reyners, Ed Schuuring*

*Corresponding author voor dit werk

OnderzoeksoutputAcademicpeer review

38 Citaten (Scopus)
190 Downloads (Pure)


Circulating cell-free DNA (ccfDNA) may contain DNA originating from the tumor in plasma of cancer patients (ctDNA) and enables noninvasive cancer diagnosis, treatment predictive testing, and response monitoring. A recent multicenter evaluation of workflows by the CANCER-ID consortium using artificial spiked-in plasma showed significant differences and consequently the importance of carefully selecting ccfDNA extraction methods. Here, the quantity and integrity of extracted ccfDNA from the plasma of cancer patients were assessed. Twenty-one cancer patient-derived cell-free plasma samples were selected to compare the Qiagen CNA, Maxwell RSC ccfDNA plasma, and Zymo manual quick ccfDNA kit. High-volume citrate plasma samples collected by diagnostic leukapheresis from six cancer patients were used to compare the Qiagen CNA (2 mL) and QIAamp MinElute ccfDNA kit (8 mL). This study revealed similar integrity and similar levels of amplified short-sized fragments and tumor-specific mutants comparing the CNA and RSC kits. However, the CNA kit consistently showed the highest yield of ccfDNA and short-sized fragments, while the RSC and ME kits showed higher variant allelic frequencies (VAFs). Our study pinpoints the importance of standardizing preanalytical conditions as well as consensus on defining the input of ccfDNA to accurately detect ctDNA and be able to compare results in a clinical routine practice, within and between clinical studies.

Originele taal-2English
Aantal pagina's14
Nummer van het tijdschrift5
StatusPublished - mei-2020


Duik in de onderzoeksthema's van 'Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer Patients'. Samen vormen ze een unieke vingerafdruk.

Citeer dit